{"id":{"repo_id":"goettingen","oai_identifier":"oai:ediss.uni-goettingen.de:11858/00-1735-0000-0006-B1AB-F"},"canonical_url":"https://search.dev.ndltd.org/etd/goettingen/oai:ediss.uni-goettingen.de:11858/00-1735-0000-0006-B1AB-F","repository":{"repo_id":"goettingen","name":"Georg-August-Universität Göttingen","base_url":"https://ediss.uni-goettingen.de/oai/request"},"display":{"title":"Analyse von Effizienz und Komplikationen der Lipidaphereselangzeittherapie","abstract":"Retrospektive Auswertung über 20 Jahre an 38 Patienten, welche mit verschiedenen Formen der Lipidapherese behandelt wurden. Ausgewertet wurden Effizienz, Verträglichkeit und Nebenwirkungen der Therapieverfahren HELP, DALI, Immunadsorbtion und Dextran-Sulfat-Adsorption. Primäre und kombinierte Endpunkte waren Kardiovaskuläre Ereignisse (Tod, Zerebralvaskuläre Ereignisse, Myokardinfarkt, Amputation, Niereninsuffizienz). Die Auswertung zeigt, dass eine Minimierung von Endorganschäden erzielt wird, die Verfahren sicher und sinnvoll bei entsprechender Indikation sind.","abstract_html":"Retrospektive Auswertung über 20 Jahre an 38 Patienten, welche mit verschiedenen Formen der Lipidapherese behandelt wurden. Ausgewertet wurden Effizienz, Verträglichkeit und Nebenwirkungen der Therapieverfahren HELP, DALI, Immunadsorbtion und Dextran-Sulfat-Adsorption. Primäre und kombinierte Endpunkte waren Kardiovaskuläre Ereignisse (Tod, Zerebralvaskuläre Ereignisse, Myokardinfarkt, Amputation, Niereninsuffizienz). Die Auswertung zeigt, dass eine Minimierung von Endorganschäden erzielt wird, die Verfahren sicher und sinnvoll bei entsprechender Indikation sind.","abstract_has_math":false,"creators":["Hennig, Ulrich"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Koziolek, Michael PD Dr.","Müller, Anton Prof. Dr.","Riggert, Joachim PD Dr.","Oppermann, Martin Prof. Dr."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012-04-16T17:24:52Z","date_published":"2012-04-16T17:24:52Z","updated_at":"2026-07-24T02:24:11Z","subjects":["610 Medizin, Gesundheit","Medicine","Hypercholesterinämie","LDL","Apherese","Sicherheit","Endorganschäden","HELP","DALI","Immunadsorption","Futura","Dextransulfat-Adsorption","hypercholesterolemia","apheresis","dextrane-sulfor-adsorption","44.61","MED 418: Nephrologie"],"languages":["ger"],"rights":[],"rights_urls":["https://creativecommons.org/licenses/by-nc-nd/3.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dx.doi.org/10.53846/goediss-947","urn:nbn:de:gbv:7-webdoc-2835-2","webdoc-2835","656433698"],"render_values":[{"text":"https://dx.doi.org/10.53846/goediss-947","href":"https://dx.doi.org/10.53846/goediss-947","code":true},{"text":"urn:nbn:de:gbv:7-webdoc-2835-2","href":null,"code":true},{"text":"webdoc-2835","href":null,"code":true},{"text":"656433698","href":null,"code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/11858/00-1735-0000-0006-B1AB-F","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Koziolek, Michael PD Dr.","Müller, Anton Prof. Dr.","Riggert, Joachim PD Dr.","Oppermann, Martin Prof. Dr."]},{"key":"dc:creator","label":"Author","values":["Hennig, Ulrich"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2012-04-16T17:24:52Z","2013-01-30T23:50:24Z","2011-02-23","2011-02-22"]},{"key":"dc:type","label":"Dc Type","values":["doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["610 Medizin, Gesundheit","Medicine","Hypercholesterinämie","LDL","Apherese","Sicherheit","Endorganschäden","HELP","DALI","Immunadsorption","Futura","Dextransulfat-Adsorption","hypercholesterolemia","apheresis","dextrane-sulfor-adsorption","44.61","MED 418: Nephrologie"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["ger"]},{"key":"dc:rights","label":"Dc Rights","values":["https://creativecommons.org/licenses/by-nc-nd/3.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/11858/00-1735-0000-0006-B1AB-F","https://dx.doi.org/10.53846/goediss-947","urn:nbn:de:gbv:7-webdoc-2835-2","webdoc-2835","656433698"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Retrospektive Auswertung über 20 Jahre an 38 Patienten, welche mit verschiedenen Formen der Lipidapherese behandelt wurden. Ausgewertet wurden Effizienz, Verträglichkeit und Nebenwirkungen der Therapieverfahren HELP, DALI, Immunadsorbtion und Dextran-Sulfat-Adsorption. Primäre und kombinierte Endpunkte waren Kardiovaskuläre Ereignisse (Tod, Zerebralvaskuläre Ereignisse, Myokardinfarkt, Amputation, Niereninsuffizienz). Die Auswertung zeigt, dass eine Minimierung von Endorganschäden erzielt wird, die Verfahren sicher und sinnvoll bei entsprechender Indikation sind.","Retrospective analysis over 20 years on 38 patients, which were treated with lipid apheresis. Efficiency, compatibleness and adverse effects of the procedures HELP, DALI immunadsorption and dextrane-sulfor-adsorption were evaluated. The incidences of major cardiovascular events (MACE) (death, cerebrovascular accident, myocardial infarction, limb amputation, and renal vascular involvement) were taken separately as primary end-points or as a combined end-point. The Evaluation of the treatment shows a minimization of these Endpoints under treatment an the safeness of the procedures."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Analyse von Effizienz und Komplikationen der Lipidaphereselangzeittherapie","analysis of efficiency and complications on long-term lipid apheresis"]}]}],"canonical_facts":{"dc:contributor":["Koziolek, Michael PD Dr.","Müller, Anton Prof. Dr.","Riggert, Joachim PD Dr.","Oppermann, Martin Prof. Dr."],"dc:creator":["Hennig, Ulrich"],"dc:date":["2012-04-16T17:24:52Z","2013-01-30T23:50:24Z","2011-02-23","2011-02-22"],"dc:description":["Retrospektive Auswertung über 20 Jahre an 38 Patienten, welche mit verschiedenen Formen der Lipidapherese behandelt wurden. Ausgewertet wurden Effizienz, Verträglichkeit und Nebenwirkungen der Therapieverfahren HELP, DALI, Immunadsorbtion und Dextran-Sulfat-Adsorption. Primäre und kombinierte Endpunkte waren Kardiovaskuläre Ereignisse (Tod, Zerebralvaskuläre Ereignisse, Myokardinfarkt, Amputation, Niereninsuffizienz). Die Auswertung zeigt, dass eine Minimierung von Endorganschäden erzielt wird, die Verfahren sicher und sinnvoll bei entsprechender Indikation sind.","Retrospective analysis over 20 years on 38 patients, which were treated with lipid apheresis. Efficiency, compatibleness and adverse effects of the procedures HELP, DALI immunadsorption and dextrane-sulfor-adsorption were evaluated. The incidences of major cardiovascular events (MACE) (death, cerebrovascular accident, myocardial infarction, limb amputation, and renal vascular involvement) were taken separately as primary end-points or as a combined end-point. The Evaluation of the treatment shows a minimization of these Endpoints under treatment an the safeness of the procedures."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/11858/00-1735-0000-0006-B1AB-F","https://dx.doi.org/10.53846/goediss-947","urn:nbn:de:gbv:7-webdoc-2835-2","webdoc-2835","656433698"],"dc:language":["ger"],"dc:rights":["https://creativecommons.org/licenses/by-nc-nd/3.0/"],"dc:subject":["610 Medizin, Gesundheit","Medicine","Hypercholesterinämie","LDL","Apherese","Sicherheit","Endorganschäden","HELP","DALI","Immunadsorption","Futura","Dextransulfat-Adsorption","hypercholesterolemia","apheresis","dextrane-sulfor-adsorption","44.61","MED 418: Nephrologie"],"dc:title":["Analyse von Effizienz und Komplikationen der Lipidaphereselangzeittherapie","analysis of efficiency and complications on long-term lipid apheresis"],"dc:type":["doctoralThesis"]},"updated_at":"2026-07-24T02:24:11Z"}